AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
Log in

LON:BMKBenchmark Share Price, Forecast & News

GBX 30
0.00 (0.00 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
29
Now: GBX 30
30.50
50-Day Range
29
MA: GBX 31.86
34.50
52-Week Range
24
Now: GBX 30
56.90
Volume151,276 shs
Average Volume102,168 shs
Market Capitalization£200.28 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Benchmark Holdings plc, together with its subsidiaries, provides technical services, products, and specialist knowledge for the development of food and farming industries worldwide. The company operates through Animal Health, Benchmark Genetics, Advanced Animal Nutrition, and All Other segments. The Animal Health segment provides veterinary and environmental diagnostics services, and animal health products to aquaculture, as well as manufactures licensed veterinary vaccines and components. The Benchmark Genetics segment offers salmon breeding technologies and production facilities to the harnesses industry to provide a range of genetic merit ova. The Advanced Animal Nutrition segment manufactures and offers nutrition and health products to the aquaculture industry. The All Other segment provides sustainable food production and technical consultancy, and assurance services; and promotes sustainable food production and ethics through online news and technical publications for the international agriculture and food processing sectors, as well as through delivery of training courses to industries. Benchmark Holdings plc was founded in 2000 and is headquartered in Sheffield, the United Kingdom.
Read More
Benchmark logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.99 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-114-2409935

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£122.75 million
Cash FlowGBX 3.10 per share
Book ValueGBX 49 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap£200.28 million
Next Earnings Date5/29/2020 (Estimated)
OptionableNot Optionable

Receive BMK News and Ratings via Email

Sign-up to receive the latest news and ratings for BMK and its competitors with MarketBeat's FREE daily newsletter.

Benchmark (LON:BMK) Frequently Asked Questions

How has Benchmark's stock been impacted by COVID-19 (Coronavirus)?

Benchmark's stock was trading at GBX 34.25 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BMK shares have decreased by 12.4% and is now trading at GBX 30. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Benchmark?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Benchmark in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Benchmark.

When is Benchmark's next earnings date?

Benchmark is scheduled to release its next quarterly earnings announcement on Friday, May 29th 2020. View our earnings forecast for Benchmark.

What price target have analysts set for BMK?

1 Wall Street analysts have issued 1-year price objectives for Benchmark's stock. Their forecasts range from GBX 92 to GBX 92. On average, they expect Benchmark's stock price to reach GBX 92 in the next year. This suggests a possible upside of 206.7% from the stock's current price. View analysts' price targets for Benchmark.

Has Benchmark been receiving favorable news coverage?

Headlines about BMK stock have been trending very negative this week, according to InfoTrie Sentiment. The research group ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Benchmark earned a news impact score of -3.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the near future. View the latest news aboutBenchmark.

Who are some of Benchmark's key competitors?

What other stocks do shareholders of Benchmark own?

Who are Benchmark's key executives?

Benchmark's management team includes the following people:
  • Mr. Malcolm David Foster Pye, CEO & Exec. Director (Age 62)
  • Mr. Mark James Plampin, CFO & Exec. Director (Age 51)
  • Ms. Ruth Layton, Co-Founder & Head of Benchmark Sustainability Science
  • Dr. Alexander Josef Raeber, Chief Scientific Officer & Exec. Director (Age 58)
  • Ms. Ivonne Cantu, Director of Investor Relations Director & Corp. Devel.

What is Benchmark's stock symbol?

Benchmark trades on the London Stock Exchange (LON) under the ticker symbol "BMK."

How do I buy shares of Benchmark?

Shares of BMK and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Benchmark's stock price today?

One share of BMK stock can currently be purchased for approximately GBX 30.

How big of a company is Benchmark?

Benchmark has a market capitalization of £200.28 million and generates £122.75 million in revenue each year.

What is Benchmark's official website?

The official website for Benchmark is www.benchmarkplc.com.

How can I contact Benchmark?

Benchmark's mailing address is Benchmark House, 8 Smithy Wood Drive, SHEFFIELD, S35 1QN, United Kingdom. The company can be reached via phone at +44-114-2409935.

This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.